Literature DB >> 22041673

[Clinical results after all arthroscopic reduction and fixation of bony Bankart lesion].

Yi-Ming Zhu1, Chun-Yan Jiang, Yi Lu, Qing-Yun Xue.   

Abstract

OBJECTIVE: To investigate the shoulder function after arthroscopic reduction and internal fixation in patients with bony Bankart lesion.
METHODS: Between May 2004 and May 2008, 45 patients with bony Bankart lesion who were treated with all arthroscopic reduction and internal fixation with metal anchors were included in this study. Among them 40 patients were male and 5 patients were female. The average age at the surgery was 27.6 years (16.5 - 50.1 years). The average duration of follow-up was 29.7 months (24.8 - 49.0 months). A history of recurrent dislocation of affected shoulder was found in all patients. Metal anchors were used to fix the bony Bankart lesion during the surgery. Hill-Sachs remplissage technique was used to treat the Engaging Hill-Sachs lesion. The preoperative American Shoulder and Elbow Society (ASES) score, Constant-Murley score, Rowe score and the VAS score for instability were 84 ± 14, 95.1 ± 4.6, 39.4 ± 2.9 and 5 ± 3 respectively.
RESULTS: No significant change was found regarding active forward elevation, external rotation and internal rotation after the surgery. The ASES score, Constant-Murley score, Rowe score and the VAS score of stability were 95 ± 7, 98.3 ± 2.2, 84.5 ± 22.0 and 1 ± 2, improved significantly higher after the surgery (P < 0.01). One subluxation and 3 redislocation were happened during follow-up. The overall failure rate was 8.9% (4/45).
CONCLUSIONS: All arthroscopic reduction and fixation of bony Bankart lesion can achieve a good result.

Entities:  

Mesh:

Year:  2011        PMID: 22041673     DOI: 10.3760/cma.j.issn.0529-5815.2011.07.007

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  1 in total

1.  Arthroscopic Bankart repair: Have we finally reached a gold standard?

Authors:  Alessandro Castagna; Raffaele Garofalo; Marco Conti; Brody Flanagin
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-29       Impact factor: 4.342

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.